APA (7th ed.) Citation

CE, R. D., MT, G., M, M., F, G., C, T., MG, F., . . . MF, J. (2026). From trial to practice: Real-world outcomes of neoadjuvant chemoimmunotherapy versus chemotherapy ± radiotherapy in resectable locally advanced NSCLC. Cirugia espanola, 800330. https://doi.org/10.1016/j.cireng.2026.800330

Chicago Style (17th ed.) Citation

CE, Rivas Duarte, Gómez-Hernández MT, Manama M, Gómez F, Taboada C, Fuentes MG, Colmenares O, and Jiménez MF. "From Trial to Practice: Real-world Outcomes of Neoadjuvant Chemoimmunotherapy Versus Chemotherapy ± radiotherapy in Resectable Locally Advanced NSCLC." Cirugia Espanola 2026: 800330. https://doi.org/10.1016/j.cireng.2026.800330.

MLA (9th ed.) Citation

CE, Rivas Duarte, et al. "From Trial to Practice: Real-world Outcomes of Neoadjuvant Chemoimmunotherapy Versus Chemotherapy ± radiotherapy in Resectable Locally Advanced NSCLC." Cirugia Espanola, 2026, p. 800330, https://doi.org/10.1016/j.cireng.2026.800330.